Effect of saptachakra ghanavati in the treatment of pain during menstruation.

A randomized open labelled control clinical trial to evaluate the efficacy of saptachakra ghanavati in the management of Spasmodic dysmenorrhea

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029731

Enrollment

120

Registered

2020-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Saptachakra ghana vati: 500mg two times a day after food with luke warm water Control Intervention1: Rajapravartini Vati: 250mg Three time a day after food with water

Eligibility

Inclusion criteria

Inclusion criteria: 1. Unmarried women, with regular cycle who complaint of painful menstruation, 2. without pelvic pathology

Exclusion criteria

Exclusion criteria: 1. PID, endometriosis and debilitating pathological conditions of the pelvic organs , Women Suffering from systemic diseases, with organic lesion (benign or malignant growth of reproductive tract), any degree of prolapsed and Hypoplastic uterus, 2.Polycystic ovarian disease (pcod), any congenital abnormality of genital organs 3.Married women and irregular cycles 4.The age beyond the 25years.

Design outcomes

Primary

Measure	Time frame
Relief from pain facilitation of normal menstrual flowTimepoint: The patients are fallowed in the interval of 7days	—

Secondary

Measure	Time frame
regulerising meneses without complications.Timepoint: outcomes regularly monitored every 1 month for the period of 3 months	—

Countries

India

Contacts

Public ContactDr Vasanthi Thondambatti

Parul Institute of Ayurved and Research

dr.vasanthi.bams@gmail.com9490887152

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026